Taxas de retenção de infliximabe e tocilizumabe no período de 3 anos em um hospital brasileiro / Retention rates of infliximab and tocilizumab during a 3-year period in a Brazilian hospital
Einstein (Säo Paulo)
;
11(4): 492-494, out.-dez. 2013. tab
Article
in Portuguese
| LILACS
| ID: lil-699862
RESUMO
OBJETIVO:
Comparar a eficácia e período de uso de tocilizumabe e infliximabe no tratamento de pacientes com artrite reumatoide.MÉTODOS:
Foi comparado o tempo de uso de dois biológicos com diferentes mecanismos de ação no tratamento de pacientes com artrite reumatoide.RESULTADOS:
Ambos os biológicos se mostraram eficazes, mas o tempo de uso sem perda de eficácia foi maior com tocilizumabe quando comparado ao infliximabe.CONCLUSÃO:
Tocilizumabe mantém um período de uso significativamente maior do que infliximabe em pacientes com artrite reumatoide tratados em uma única instituição.ABSTRACT
OBJECTIVE:
To compare the efficacy and the period of use of tocilizumab and infliximab during treatment of rheumatoid arthritis patients.METHODS:
The period of use of two biologics with different mechanisms of action were compared in treatment of rheumatoid arthritis patients. RES ULTS Both medications showed efficacy, but the period of use with no loss of efficacy was longer in patients receiving tocilizumab when compared to infliximab.CONCLUSION:
Tocilizumab maintains a period of use significantly longer as compared with infliximab in patients with rheumatoid arthritis treated at a single organization.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Arthritis, Rheumatoid
/
Antirheumatic Agents
/
Antibodies, Monoclonal, Humanized
/
Antibodies, Monoclonal
Limits:
Humans
Country/Region as subject:
South America
/
Brazil
Language:
Portuguese
Journal:
Einstein (Säo Paulo)
Journal subject:
Medicine
Year:
2013
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital Israelita Albert Einstein/BR
Similar
MEDLINE
...
LILACS
LIS